Dewhirst MW - Search Results

1

Temperature matters! And why it should matter to tumor immunologists.

Repasky EA, Evans SS, Dewhirst MW. Repasky EA, et al. Among authors: dewhirst mw. Cancer Immunol Res. 2013 Oct;1(4):210-6. doi: 10.1158/2326-6066.CIR-13-0118. Cancer Immunol Res. 2013. PMID: 24490177 Free PMC article. Review.

2

IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells.

Fisher DT, Chen Q, Skitzki JJ, Muhitch JB, Zhou L, Appenheimer MM, Vardam TD, Weis EL, Passanese J, Wang WC, Gollnick SO, Dewhirst MW, Rose-John S, Repasky EA, Baumann H, Evans SS. Fisher DT, et al. Among authors: dewhirst mw. J Clin Invest. 2011 Oct;121(10):3846-59. doi: 10.1172/JCI44952. Epub 2011 Sep 19. J Clin Invest. 2011. PMID: 21926464 Free PMC article.

3

Can Exercise-Induced Modulation of the Tumor Physiologic Microenvironment Improve Antitumor Immunity?

Zhang X, Ashcraft KA, Betof Warner A, Nair SK, Dewhirst MW. Zhang X, et al. Among authors: dewhirst mw. Cancer Res. 2019 May 15;79(10):2447-2456. doi: 10.1158/0008-5472.CAN-18-2468. Epub 2019 May 8. Cancer Res. 2019. PMID: 31068341 Free PMC article. Review.

4

Thermal cycling enhances the accumulation of a temperature-sensitive biopolymer in solid tumors.

Dreher MR, Liu W, Michelich CR, Dewhirst MW, Chilkoti A. Dreher MR, et al. Among authors: dewhirst mw. Cancer Res. 2007 May 1;67(9):4418-24. doi: 10.1158/0008-5472.CAN-06-4444. Cancer Res. 2007. PMID: 17483356

5

A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model.

Needham D, Anyarambhatla G, Kong G, Dewhirst MW. Needham D, et al. Among authors: dewhirst mw. Cancer Res. 2000 Mar 1;60(5):1197-201. Cancer Res. 2000. PMID: 10728674

6

Direct demonstration of instabilities in oxygen concentrations within the extravascular compartment of an experimental tumor.

Lanzen J, Braun RD, Klitzman B, Brizel D, Secomb TW, Dewhirst MW. Lanzen J, et al. Among authors: dewhirst mw. Cancer Res. 2006 Feb 15;66(4):2219-23. doi: 10.1158/0008-5472.CAN-03-2958. Cancer Res. 2006. PMID: 16489024

7

Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting.

Dewhirst MW. Dewhirst MW. Cancer Res. 2007 Feb 1;67(3):854-5. doi: 10.1158/0008-5472.CAN-06-4744. Cancer Res. 2007. PMID: 17283112 Review.

8

Oxygen-Enhanced MRI Is a Major Advance in Tumor Hypoxia Imaging.

Dewhirst MW, Birer SR. Dewhirst MW, et al. Cancer Res. 2016 Feb 15;76(4):769-72. doi: 10.1158/0008-5472.CAN-15-2818. Epub 2016 Feb 2. Cancer Res. 2016. PMID: 26837768 Review. No abstract available.

9

Enhancement of hypoxia-induced tumor cell death in vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor-1alpha.

Zhang X, Kon T, Wang H, Li F, Huang Q, Rabbani ZN, Kirkpatrick JP, Vujaskovic Z, Dewhirst MW, Li CY. Zhang X, et al. Among authors: dewhirst mw. Cancer Res. 2004 Nov 15;64(22):8139-42. doi: 10.1158/0008-5472.CAN-03-2301. Cancer Res. 2004. PMID: 15548675

10

Tumor cells upregulate normoxic HIF-1α in response to doxorubicin.

Cao Y, Eble JM, Moon E, Yuan H, Weitzel DH, Landon CD, Nien CY, Hanna G, Rich JN, Provenzale JM, Dewhirst MW. Cao Y, et al. Among authors: dewhirst mw. Cancer Res. 2013 Oct 15;73(20):6230-42. doi: 10.1158/0008-5472.CAN-12-1345. Epub 2013 Aug 19. Cancer Res. 2013. PMID: 23959856 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

611 results

Search Page